Endpoints News 生物医药· Lei Lei Wu·· 2026-10-16AI 评分51
诺华终止Fabhalta狼疮性肾炎中期临床试验
Novartis scraps Fabhalta study in lupus nephritis
AI 导读
美国联邦临床试验数据库记录显示,诺华基于战略考量终止了Fabhalta在狼疮性肾炎治疗中的中期临床试验。Fabhalta亦称ipatacicept,是一种免疫调节药物。由于原文被付费墙限制,具体试验阶段及详细数据未能显示。
正文
Novartis terminated a mid-stage trial of Fabhalta in lupus nephritis, citing “strategic considerations,” according to a federal clinical trials database.
Fabhalta, also known as iptacopan …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news